Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
VTYX
Home
/
VTYX

NASDAQ
$14
$14

Overview

Price performance
Low
$14.00
High
$14.00
Market closed. Last updated: Mar 6, 2026, 2:30 PM UTC
$
14.00
0.00 (0.00%)
Average, 50 days
$12.84
$6.40
Open
$14.00
Previous close
$14.00
52-week high
$25.00
Jan 6, 2026 (11 months ago)
52-week low
$7.08
Jan 6, 2026 (11 months ago)
97.74%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
1.00B
Volume
5 403 471
Total Return (3M)
79.03%
Total Return (1Y)
1574.44%
155.50
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
lilly.com
About
Ventyx Biosciences, Inc. is a biopharmaceutical company in the clinical development phase, specializing in the creation of small molecule therapeutics for inflammatory and autoimmune disorders. The company's primary investigational drug, VTX958, a tyrosine kinase type 2 (TYK2) inhibitor, is currently undergoing Phase I clinical trials. This compound aims to address a range of immune-mediated conditions, including psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. Among its pipeline assets is VTX002, an oral sphingosine 1 phosphate receptor 1 (S1P1) modulator, which has advanced to Phase II clinical studies for the treatment of ulcerative colitis. Additionally, VTX2735, a peripherally targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor, is in Phase I development, intended to combat systemic inflammatory diseases affecting cardiovascular, hepatic, renal, and rheumatologic systems. Furthermore, Ventyx is engaged in the development of CNS-penetrant NLRP3 inhibitors, with the objective of providing therapies for neurological ailments such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. Founded in 2018, Ventyx Biosciences, Inc. is headquartered in Encinitas, California.

Frequently asked questions

VTYX · Ventyx Biosciences, Inc.

01What is Ventyx Biosciences, Inc. stock price today?

The current price of VTYX is $14.00 — it has remained unchanged since the previous close. Data as of Mar 6, 2026.

02Is Ventyx Biosciences, Inc. stock price growing?

VTYX is flat over the past week, flat over the past month and up 1,574.44% over the past year. The price is above its 200-day moving average of $6.40.

03What do analysts say about VTYX stock?

Of the 8 analysts covering Ventyx Biosciences, Inc., 1 rates it a buy and 7 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.

04What is Ventyx Biosciences, Inc. market cap?

Ventyx Biosciences, Inc. has a market capitalization of $1B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

05Does Ventyx Biosciences, Inc. pay dividends?

Ventyx Biosciences, Inc. has not paid any dividends over the past year.

06How volatile is VTYX stock?

In the latest trading session VTYX moved between $14.00 and $14.00, a range of 0.00% of its current price.

07Should I invest in Ventyx Biosciences, Inc. stock?

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Ventyx Biosciences, Inc. shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Ventyx Biosciences, Inc. is buy. Technical ratings are indicators, not investment advice.

08What are VTYX stock 52-week high and low?

Over the past 52 weeks VTYX has traded between $7.08 and $25.00. The current price is 44.00% below its 52-week high.

Figures as of Mar 6, 2026. This information is provided for general purposes only and is not investment advice.